Information Library
Results for: Oncology - North and Central America
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
ASCO 2012
Event — Conference Date(s): June 1 - June 5, 2012
Location: Chicago, IL McCormick Place
Booth Number: 2062
-
CBI Oncology Commercialization Strategies
Event — Conference Date(s): January 24 - January 26, 2012
Location: Philadelphia, PA Radisson Plaza Warwick Hotel
Booth Number: NA
-
Energizing Enrollment
Case Study — October 4, 2011
The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned. -
Genomics Fact Sheet
Brochure — June 17, 2011
Approximately 20% of today’s U.S. Clinical Trials use genomic technology. Find out about Quintiles’ offerings in this area. -
Quintiles and Population Genetics Technologies Partner
Press Release — May 16, 2011 – Quintiles, and Population Genetics Technologies Ltd. (PGT), announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.
-
Dr. Frank Massam
Hear from the Experts — May 13, 2011
Dr. Frank Massam discusses the significance of Quintiles' partnership with Population Genetics Technologies Ltd. -
Oncology Expertise - Scientific Collaborator for Global Solutions
Brochure — January 28, 2011
Whether you wish to use one of our existing assays, need assistance with developing a new assay, or plan to deploy an assay developed by your diagnostic partner, as your collaborator, Quintiles has the scientific expertise, resources, and flexibility to develop the right solution for you. -
Quintiles Speeds Early-Phase Decision Making with New Unit in Hyderabad, India
Press Release — January 24, 2011 – Quintiles officially opened its new Phase I research facility in Hyderabad, India at Apollo Health City.
-
Clinical Trials: Race to Study Launch & Speed to Finish
Presentation — July 2, 2010
Chris Cabell's presentation at DIA US 2010 - Clinical Trials:Race to Study Launch and Speed to Finish -
QUINTILES ANNOUNCES SUITE OF PI3K BIOMARKER ASSAYS TO ADVANCE ONCOLOGY THERAPIES TARGETING THIS CANCER PATHWAY
Press Release — June 7, 2010 - Suite is part of Quintiles Global Central Labs’ ongoing efforts to advance personalized medicine.
